Product Images Abstral

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Abstral NDC 57881-333 by Galena Biopharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - abs02 0001 01

Figure - abs02 0001 01

This is a description of the titration process for ABSTRAL, a medication used for pain relief. The initial dose is 100mg and if adequate pain relief is achieved within 30 minutes, subsequent doses are increased incrementally for breakthrough pain. Doses should be separated by at least 2 hours. The text also includes information on dosing for different strength tablets, up to a maximum of 500mg.*

Structural Formula - abs02 0001 02

Structural Formula - abs02 0001 02

Figure 1 - abs02 0001 03

Figure 1 - abs02 0001 03

Figure 2 - abs02 0001 04

Figure 2 - abs02 0001 04

Figures 1 and 2 - abs02 0001 05

Figures 1 and 2 - abs02 0001 05

Figures 3 and 4 - abs02 0001 06

Figures 3 and 4 - abs02 0001 06

Figures 5, 6, and 7 - abs02 0001 07

Figures 5, 6, and 7 - abs02 0001 07

Principal Display Panel – 100 mcg Carton Label - abs02 0001 08

Principal Display Panel – 100 mcg Carton Label - abs02 0001 08

ABSTRAL® is a brand of sublingual tablets containing fentanyl, an opioid used for severe pain relief. It comes in a pack of 32 sublingual tablets, and each tablet is not meant to be chewed or swallowed. ABSTRAL® comes with an application guide enclosed, for sublingual administration only. The manufacturer, Pharmaceutics International, is located in Hunt Valley, MD, and the product is distributed by Galena Bopharma, in Lake Oswego, OR. Access to ABSTRAL® is restricted to patients with a prescription, and a TIRF REM access program is applicable. For more information, call 1-883-ABSTRAL.*

Principal Display Panel – 200 mcg Carton Label - abs02 0001 09

Principal Display Panel – 200 mcg Carton Label - abs02 0001 09

ABSTRAL®C is a medication for sublingual administration that comes in the form of fentanyl sublingual tablets. It includes important safety information that can be found in the enclosed medication guide. Patients should not chew or swallow the tablet whole. The drug should be given to patients for whom it is prescribed. Questions about the product can be addressed by calling 1-863-ABSTRAL.*

Principal Display Panel – 300 mcg Carton Label - abs02 0001 10

Principal Display Panel – 300 mcg Carton Label - abs02 0001 10

Principal Display Panel – 400 mcg Carton Label - abs02 0001 11

Principal Display Panel – 400 mcg Carton Label - abs02 0001 11

ABSTRAL®G is a sublingual tablet containing fentanyl used for pain management. The package contains 32 sublingual tablets, and each tablet should not be chewed or swallowed whole. There are important safety instructions enclosed in the ABSTRAL® medication guide to be followed while using it. The medication is distributed through a TIRF REMS access program. For queries or questions about ABSTRAL®, call 1-888 ABSTRAL.*

Principal Display Panel – 600 mcg Carton Label - abs02 0001 12

Principal Display Panel – 600 mcg Carton Label - abs02 0001 12

Principal Display Panel – 800 mcg Carton Label - abs02 0001 13

Principal Display Panel – 800 mcg Carton Label - abs02 0001 13

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.